PUT/INTUITIVE SURGICAL/500/0.01/20.06.25 Share Price

Warrant

DE000GG4UJM1

Real-time Bid/Ask 06:11:06 02/07/2024 pm IST
0.75 EUR / 0.77 EUR +10.14% Intraday chart for PUT/INTUITIVE SURGICAL/500/0.01/20.06.25
1 month-26.60%
3 months-31.00%
Date Price Change
01/24/01 0.69 0.00%
28/24/28 0.69 -1.43%
27/24/27 0.7 -10.26%
25/24/25 0.78 +4.00%
24/24/24 0.75 -2.60%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 01:43 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
Issuer Goldman Sachs
WKN GG4UJM
ISINDE000GG4UJM1
Date issued 05/03/2024
Strike 500 $
Maturity 20/06/2025 (353 Days)
Parity 100 : 1
Emission price 0.97
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.26
Lowest since issue 0.69
Delta-0.53x
Omega 2.894
Premium3.84x
Gearing5.42x
Moneyness 1.146
Difference Strike 63 $
Difference Strike %+12.60%
Spread 0.02
Spread %2.63%
Theoretical value 0.7600
Implied Volatility 34.26 %
Total Loss Probability 33.92 %
Intrinsic value 0.5940
Present value 0.1660
Break even 418.42 €
Theta-0x
Vega0.02x
Rho-0.03x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
436.2 USD
Average target price
426.5 USD
Spread / Average Target
-2.24%
Consensus